Nivolumab (Opdivo): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
18 October 2019

Abstract

Patients on nivolumab who present with diarrhoea or other symptoms of colitis, and those who do not respond to steroid treatment for immune-related colitis, should be investigated to exclude other causes, including infection…